Aqueous Interleukin-6 Levels Are Superior to Vascular Endothelial Growth Factor in Predicting Therapeutic Response to Bevacizumab in Age-Related Macular Degeneration

Objective. To prospectively evaluate the effect of intravitreal bevacizumab on aqueous levels of interleukin-6 (IL-6) and vascular endothelial growth factor (VEGF) in patients with exudative age-related macular degeneration (AMD) and correlate clinical outcomes with cytokine levels. Methods. 30 eyes...

Descripción completa

Detalles Bibliográficos
Autores principales: Chalam, Kakarla V., Grover, Sandeep, Sambhav, Kumar, Balaiya, Sankarathi, Murthy, Ravi K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4121253/
https://www.ncbi.nlm.nih.gov/pubmed/25110587
http://dx.doi.org/10.1155/2014/502174

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4121253/
https://www.ncbi.nlm.nih.gov/pubmed/25110587
http://dx.doi.org/10.1155/2014/502174

Ejemplares similares